Kimberly A Chianese-Bullock

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Cross Sectional

Top Venues

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Emily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, Margaret von Mehren, Naomi B Haas, Merrick I Ross, Lynn T Dengel, Craig L Slingluff
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial. Nature communications 15 (1) (2024)
Emily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, Margaret von Mehren, Naomi B Haas, Merrick I Ross, Lynn T Dengel, Craig L Slingluff
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial. Nature communications 15 (1) (2024)
Emily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, Margaret von Mehren, Naomi B Haas, Merrick I Ross, Lynn T Dengel, Craig L Slingluff
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial. Nature communications 15 (1) (2024)
Amanda M Lulu, Kara L Cummings, Erin D Jeffery, Paisley T Myers, Dennis Underwood, Rachel M Lacy, Kimberly A Chianese-Bullock, Craig L Slingluff, Susan C Modesitt, Victor H Engelhard
Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients. Cancer immunology research 9 (11) (2021)